Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Medtronic plc from 28 Apr 2017 to 25 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Medtronic plc quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 28 Apr 2017 to 25 Jul 2025.
  • Medtronic plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 25 Jul 2025 was $945,000,000, a 3600% decline year-over-year.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $934,000,000.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $259,000,000, a 88% increase from 2022.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $2,171,000,000, a 1894% decline from 2021.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

Medtronic plc Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $945,000,000 -$972,000,000 -3600% 26 Apr 2025 25 Jul 2025 10-Q 26 Aug 2025 2026 Q1
Q2 2024 $27,000,000 +$231,000,000 27 Apr 2024 26 Jul 2024 10-Q 26 Aug 2025 2026 Q1
Q2 2023 $204,000,000 +$1,370,000,000 +87% 29 Apr 2023 28 Jul 2023 10-Q 27 Aug 2024 2025 Q1
Q2 2022 $1,574,000,000 -$985,000,000 -167% 30 Apr 2022 29 Jul 2022 10-Q 31 Aug 2023 2024 Q1
Q2 2021 $589,000,000 -$2,948,000,000 -125% 01 May 2021 30 Jul 2021 10-Q 01 Sep 2022 2023 Q1
Q2 2020 $2,359,000,000 +$1,672,000,000 +243% 25 Apr 2020 31 Jul 2020 10-Q 02 Sep 2021 2022 Q1
Q2 2019 $687,000,000 27 Apr 2019 26 Jul 2019 10-Q 03 Sep 2020 2021 Q1

Medtronic plc Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $934,000,000 +$1,193,000,000 27 Apr 2024 25 Apr 2025 10-K 20 Jun 2025 2025 FY
2023 $259,000,000 +$1,912,000,000 +88% 29 Apr 2023 26 Apr 2024 10-K 20 Jun 2025 2025 FY
2022 $2,171,000,000 -$2,292,000,000 -1894% 30 Apr 2022 28 Apr 2023 10-K 20 Jun 2025 2025 FY
2021 $121,000,000 +$668,000,000 01 May 2021 29 Apr 2022 10-K 20 Jun 2024 2024 FY
2020 $547,000,000 -$294,000,000 -116% 25 Apr 2020 30 Apr 2021 10-K 22 Jun 2023 2023 FY
2019 $253,000,000 -$977,000,000 -135% 27 Apr 2019 24 Apr 2020 10-K 23 Jun 2022 2022 FY
2018 $724,000,000 +$2,022,000,000 28 Apr 2018 26 Apr 2019 10-K 25 Jun 2021 2021 FY
2017 $1,298,000,000 -$3,389,000,000 -162% 29 Apr 2017 27 Apr 2018 10-K 19 Jun 2020 2020 FY
2016 $2,091,000,000 30 Apr 2016 28 Apr 2017 10-K 21 Jun 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.